Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07645131
Development of a Mobile Health Intervention to Support Functioning of Veterans With Substance Use DisordersVA Office of Research and DevelopmentNot Yet RecruitingNot Applicable
NCT07645131Not Yet Recruiting
Not Applicable
Development of a Mobile Health Intervention to Support Functioning of Veterans W...VA Office of Research and...
NCT07646067
Closed Loop Glucose Control in a Simulated ICU SettingEmory UniversityNot Yet RecruitingNot Applicable
NCT07646067Not Yet Recruiting
Not Applicable
Closed Loop Glucose Control in a Simulated ICU SettingEmory University
NCT07646327
Sustained Natural Apophyseal Glides With and Without Facilitated Positional Release Technique in Cervicogenic DizzinessRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07646327Not Yet Recruiting
Not Applicable
Sustained Natural Apophyseal Glides With and Without Facilitated Positional Rele...Riphah International Univ...
NCT07644039
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced MalignanciesPharmaMarRecruitingPhase 1
NCT07644039Recruiting
Phase 1
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advan...PharmaMar
NCT07644325
Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament BiopsyClinique Saint Jean, FranceRecruitingNot Applicable
NCT07644325Recruiting
Not Applicable
Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior C...Clinique Saint Jean, Fran...
NCT07645469
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaFred Hutchinson Cancer CenterNot Yet RecruitingPhase 1
NCT07645469Not Yet Recruiting
Phase 1
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Di...Fred Hutchinson Cancer Ce...
NCT07646054
Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers23andMe, Inc.Not Yet RecruitingNot Applicable
NCT07646054Not Yet Recruiting
Not Applicable
Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers23andMe, Inc.
NCT07645170
Strain Counter-Strain vs Maitland Mobilization for Sacroiliac Joint PainUniversity of FaisalabadActive Not RecruitingNot Applicable
NCT07645170Active Not Recruiting
Not Applicable
Strain Counter-Strain vs Maitland Mobilization for Sacroiliac Joint PainUniversity of Faisalabad
NCT07645105
Body Weight Reduction and Metabolic/Biochemical Parameters in Overweight or ObesityMedical University of SilesiaCompleted
NCT07645105Completed
—
Body Weight Reduction and Metabolic/Biochemical Parameters in Overweight or Obes...Medical University of Sil...
NCT07645560
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeBeijing Tiantan HospitalNot Yet RecruitingPhase 2
NCT07645560Not Yet Recruiting
Phase 2
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After...Beijing Tiantan Hospital
NCT07645859
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuous Training in Chronic Non-Specific Low Back Pain PatientsDow University of Health SciencesRecruitingNot Applicable
NCT07645859Recruiting
Not Applicable
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuou...Dow University of Health...
NCT07644299
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Concept StudyCiusss de L'Est de l'Île de MontréalNot Yet RecruitingNot Applicable
NCT07644299Not Yet Recruiting
Not Applicable
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Co...Ciusss de L'Est de l'Île...
NCT07644481
Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete RemissionInstitute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingNot Applicable
NCT07644481Not Yet Recruiting
Not Applicable
Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melpha...Institute of Hematology &...
NCT07643935
Prognostic Value of 177Lutetium-PSMA Single Photon Emission Tomography and Timing of ResponseCentral Hospital, Nancy, FranceNot Yet Recruiting
NCT07643935Not Yet Recruiting
—
Prognostic Value of 177Lutetium-PSMA Single Photon Emission Tomography and Timin...Central Hospital, Nancy,...
NCT07644013
Prospective Multicenter Registry Study of Multiple System Atrophy in ChinaPeking University First HospitalRecruiting
NCT07644013Recruiting
—
Prospective Multicenter Registry Study of Multiple System Atrophy in ChinaPeking University First H...
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07644312
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPGNationwide Children's HospitalNot Yet RecruitingPhase 2
NCT07644312Not Yet Recruiting
Phase 2
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG...Nationwide Children's Hos...
NCT07646314
Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techniques inPiriformis SyndromeRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07646314Not Yet Recruiting
Not Applicable
Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techn...Riphah International Univ...
NCT07645495
Frequency Rhythmic Electrical Modulated Stimulation Therapy in Chronic Ulcers.Beni-Suef UniversityNot Yet RecruitingNot Applicable
NCT07645495Not Yet Recruiting
Not Applicable
Frequency Rhythmic Electrical Modulated Stimulation Therapy in Chronic Ulcers.Beni-Suef University
Result Breakdown
Not yet recruiting12 (60%)
Recruiting6 (30%)
Active, not recruiting1 (5%)
Completed1 (5%)
not_applicable11 (55%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 12 (10%)